Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN)
Conclusions:
This meta-analysis revealed that with both NSCLC and squamous cell carcinoma of the head and neck (SCCHN) patients, liposomal cisplatin-based chemotherapy offers significant advantages regarding the PD and reduced toxicities relative to conventional cisplatin.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Clinical Trials | Databases & Libraries | Head and Neck Cancer | Internal Medicine | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Skin Cancer | Squamous Cell Carcinoma | Toxicology